I've been obsessing over SGH the past couple of days, trying to figure out why people are hesitating over buying...
There are two roadblocks I see for SGH;
1) The ASIC Investigation
- Very unlikely to impact the company. The investigation (from what I understand) is looking into how they were classifying assets on their balance sheet and should not impact profit. Management have already taken positive steps to address this (correcting accounting policies & appointing a new CFO).
2) The newly introduced cap for UK claims
- Yes, it is an unfortunate event that will impact profits and I can see how this may cause fear in relation to their increased debt load, however the company's cash flows are still strong and the overall business is definitely enough to stay afloat. (see screenshot from IBIS Research).
Of course, I understand the share price is riddled with short traders and other "bad guys" but this shouldn't prevent anyone from buying at this price?
I see fields of green once this ASIC investigation is finalised.
Please let me know if I've missed something here, any feedback is much appreciated.
- Forums
- ASX - By Stock
- Keeping it Fundamental
SGH
sgh limited
Add to My Watchlist
1.10%
!
$51.40

I've been obsessing over SGH the past couple of days, trying to...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$51.40 |
Change
-0.570(1.10%) |
Mkt cap ! $20.91B |
Open | High | Low | Value | Volume |
$52.74 | $52.74 | $51.24 | $18.10M | 351.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 245 | $51.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$51.46 | 1043 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 245 | 51.200 |
1 | 115 | 51.100 |
1 | 55 | 51.010 |
1 | 98 | 50.850 |
1 | 105 | 50.800 |
Price($) | Vol. | No. |
---|---|---|
51.460 | 600 | 1 |
51.590 | 445 | 1 |
52.050 | 500 | 1 |
52.470 | 258 | 1 |
52.700 | 95 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
SGH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online